For the Inventor, By the Inventor

Enter assignee name

Seoul, South Korea

Sungkwang Medical Foundation

USPTO Granted Patents = 19

EPO Patents = 2

Trademarks = 2

Forward Citations = 7

Loading Chart...

Loading Chart...

50 inventors (with patents filed for the assignee):

Hee Jung An (7 out of 7 patents)

Young Gie Chung (4 out of 13 patents)

Dong Ryul Lee (4 out of 9 patents)

4. Ah Young Kwon (3 out of 3 patents)

5. Yong Wha Moon (3 out of 3 patents)

6. Jin Hee Eum (2 out of 2 patents)

7. Jin Sung Kim (2 out of 54 patents)

8. Se Wha Kim (2 out of 2 patents)

9. Eun Jin Lim (2 out of 2 patents)

10. Yeon Ho Choi (2 out of 6 patents)

11. Hong Jae Jeon (1 out of 1 patent)

12. Na Keum Lee (1 out of 1 patent)

13. Hye Sun Jeon (1 out of 4 patents)

14. Young Eun Kwon (1 out of 1 patent)

15. David Tae Aug Kim (1 out of 1 patent)

19 patents: Sort by Forward Citations

1. 12442041 - Epigenetic biomarker composition for diagnosing Down syndrome, and use thereof (2025-10-14),

2. 12410473 - Analytic method and kit for diagnosing alcohol use disorders (2025-09-09),

3. 12338422 - Three-dimensional biomimetic chip for simulating endometrium, and endometrium simulating method using same (2025-06-24),

4. 12274717 - PCNT as a target protein for treatment or diagnosis of brain-nervous system diseases (2025-04-14),

5. 12091679 - Storage method and banking system of NT cell (2024-09-17),

6. 11981924 - Composition for culturing NK cells and method for culturing NK cells using same (2024-05-14),

7. 11746327 - Composition for culturing NK cells and method for culturing NK cells using same (2023-09-05),

8. 11639531 - Composition, kit, and method for diagnosis and treatment of taxane anticancer agent-resistant cancer (2023-05-02),

9. 11535824 - Nuclear transfer (2022-12-27),

10. 11524036 - Method for treating thyroid associated ophthalmopathy (2022-12-13),

11. 11370758 - IDO-TDO dual inhibitor and related methods of use (2022-06-28),

12. 11339369 - Production of parthenogenetic stem cells and patient-specific human embryonic stem cells using somatic cell nuclear transfer (2022-05-24),

13. 11214558 - Synthesis method of DHPV (2022-01-04),

14. 10538817 - Method for diagnosing and treating ovarian cancer (2020-01-21),

15. 10060926 - Method for diagnosing and treating ovarian cancer (2018-08-28),

Sungkwang Medical Foundation is a leading healthcare organization dedicated to providing quality medical services. With a history spanning several decades, we have established ourselves as a trusted name in the field of healthcare, serving the community with compassion and excellence. Our medical facilities are equipped with state-of-the-art technology and staffed by highly skilled healthcare professionals. Our commitment to ongoing research and innovation allows us to offer advanced treatment options to our patients. At Sungkwang Medical Foundation, we prioritize patient care and strive to make a positive impact on the health and well-being of individuals and society as a whole.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

19 Patents

#203 in Seoul

#631 in South Korea

#31,731 in the World

Seoul, South Korea

Sungkwang Medical Foundation

Forward Citations = 7

50 inventors:

Hee Jung An (7 out of 7 patents)

Young Gie Chung (4 out of 13 patents)

Dong Ryul Lee (4 out of 9 patents)

4. Ah Young Kwon (3 out of 3 patents)

5. Yong Wha Moon (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…